Zobrazeno 1 - 10
of 158
pro vyhledávání: '"E. Dafni"'
BACKGROUND: Anti-PD-(L)1 therapy alone (cancer immunotherapy [CIT]-mono) or combined with platinum-based chemotherapy (CIT-chemo) is used as first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC). Our study compared clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::335375533bd664d12483de1f2e7316e9
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3215698
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3215698
Introduction: The NICOLAS study is the first completed single-arm phase II trial in stage III NSCLC evaluating hierarchically first the safety and then the efficacy of adding nivolumab concurrently to standard definitive concurrent chemoradiotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::98783e347b6f9e8f4895b6ff61f4aa86
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102842
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102842
Objectives: Chemo-radiotherapy (CRT) and concurrent PD-1 inhibition has shown promising results in pre-clinical models. So far, the feasibility of delivering concurrent CRT and PD-1/PD-L1 inhibition has never been assessed in a clinical trial. Materi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a3b49a135aacbe35b43c5275f2231c14
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077420
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077420
Introduction: The PD-L1 biomarker is an important factor in selecting patients with non-small cell lung cancer for immunotherapy. While several reports suggest that PD-L1 positivity is linked to a poor prognosis, others suggest that PD-L1 positive st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::71b2069f80b9ec81271a3f5b05e09b18
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077599
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077599
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background While the global workforce is approaching gender parity, women occupy a small number of management level positions across most professions, including healthcare. Although the inclusion of women into the membership of many oncology societie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7753b8cbcb7886d023e2c294cfb09cf6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086112
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086112
Background: The treatment paradigm in advanced renal cell carcinoma (RCC) has changed in the recent years. Sunitinib has been established as a new standard for first-line therapy. We studied the prognostic significance of baseline characteristics and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a77f401536dd5bdb2102e977c86bd26b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089847
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089847
Purpose/Objectives: To describe fatigue in women with breast cancer undergoing radiotherapy and to explore the impact of fatigue on their health status. Design: Prospective, descriptive, repeated measures. Setting: A major oncology center, Saint Savv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e9c07f1773ba47335a8267fe3536a6ea
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2989208
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2989208